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Abstract: Cohesin is a ring-form multifunctional protein complex, which was discovered during 
a search for molecules that keep sister chromatids together during segregation of chromosomes 
during cell division. In the past decade, a large number of results have also demonstrated a 
need for the cohesin complex in other crucial events in the life cycle of the cell, including DNA 
duplication, heterochromatin formation, DNA double-strand break repair, and control of gene 
expression. The dynamics of the cohesin ring are modulated by a number of accessory and 
regulatory proteins, known as cohesin cofactors. Loss of function of the cohesin complex is 
incompatible with life; however, mutations in the genes encoding for cohesin subunits and/or 
cohesin cofactors, which have very little or a null effect on chromosome segregation, represent 
a newly recognized class of human genetic disorders known as cohesinopathies. A number of 
genetic, biochemical, and clinical approaches, and importantly, animal models, can help us to 
determine the underlying mechanisms for these human diseases.
Keywords: cohesin, cohesinopathies, Cornelia de Lange syndrome, Roberts syndrome, control, 
gene expression, insulators
Introduction
Cells have precise mechanisms for controlling cohesion of sister chromatids during 
cell division to ensure appropriate distribution of genetic material to daughter cells. 
The main molecular entity in this process is the evolutionarily conserved cohesin 
complex. The canonical cohesin complex consists of four subunits known as 
SMC1 and SMC3 (from the structural maintenance of chromosomes family) and 
SCC1 and SCC3 (sister chromatid cohesion). The latter two subunits are also 
known as RAD21 (SCC1, kleisin) and STAG (SCC3) in mammals (Table 1). The 
cohesin complex adopts a ring-like structure, which traps the replicated DNA 
and mediates cohesion between sister chromatids (Figure 1). The dynamics of the 
cohesin ring are regulated by an undetermined number of proteins that interact 
with cohesins (Table 1). These cohesin regulators were first characterized and 
studied in relation to the cohesive function of cohesin complexes, most of which 
are involved in the dynamics of the association and/or dissociation of the cohesin 
complex with chromatin. Loading of cohesins into chromosomes depends on the 
adherin complex, which is composed of two proteins, SCC2 (also named NIPBL/
Nipped B/delangin) and SCC4 (MAU2, Figure 1). However, this loading is not 
sufficient for correct cohesive function and requires the participation of ESCO1/2 
acetyltransferases for effective cohesion. The substrate of this acetylation is the 
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SMC3 subunit of the cohesin complex (Figure 1). Others 
cohesin cofactors are PDS5 (precocious dissociation of 
sisters), WAPL (wings apart-like) and Sororin, which are 
implicated in the maintenance and/or removal of cohesins 
from chromatin (Figure 1). Although it is necessary to 
mention the role of these cohesin regulators, this is not 
the principal focus of this review, and there are already at 
least two excellent published reviews offering a detailed 
description of the function and molecular mechanisms of 
cohesin regulators.1,2
In the last few years, new functions of the cohesin 
complex have emerged in terms of genome structure 
and dynamics. The requirement for cohesin subunits and 
regulators in repair of DNA damage in different models has 
been extensively reported.3–6 Alteration of these two essential 
cell life processes by defects in the cohesin network may 
underlie chromosomal instability and aneuploidy, which are 
two principal hallmarks of tumor formation and progression.7 
One of the most surprising findings was the discovery in 
2004 of a link between cohesin gene mutations and human 
developmental abnormalities.8–10 Four years later, three 
research groups reported results indicating the molecular 
mechanisms by which cohesin metabolism could be related 
to development control. Taking into account the fact that 
cohesins are also expressed in post-mitotic cells, different 
groups have investigated these newly discovered cohesin/
chromatin interactions. The search for cohesin binding sites 
in the human genome showed overlap with CCCTC binding 
factor (CTCF) sites.11–13 CTCF is an insulator protein that 
participates in blocking enhancer-promoter interaction. These 
works pioneered the study of the function of this newly 
identified cohesin, suggesting involvement of cohesin in 
regulation of gene expression. The present review focuses 
on the links between cohesin networks and the genetic 
and molecular basis of human diseases now known as 
cohesinopathies.
Table 1 Subunits of cohesin complexes and cohesin regulators implicated in cohesinopathies
Saccharomyces 
cerevisiae
Schizosaccharomyces 
pombe
Drosophila Xenopus Mammals
Structural maintenance 
of chromosomes (SMC)
Smc1 
Smc3
Psm1 
Psm3
Smc1 
Cap/Smc3
XSMC1 
XSMC3
SMC1α 
SMC3
Meiosis-specific SMC1β
α-kleisin (from Greek 
for “closure”)
Mcd1/Scc1 Rad21 DRad21 XRAD21 RAD21
Meiosis-specific Rec8 Rec8 XREC8 REC8, RAD21L
Stromalin/HEAT repeat 
domain
Scc3/IRR1 Psc3 DSA1 XSA1, XSA2 STAG1, STAG2
Adherin (loading) Scc2 
Scc4
Mis4 
Ssl3
Nipped-B Nipbl/Scc2/delangin 
Mau2/Scc4
NIPBL/SCC2/DELANGIN 
MAU2/SCC4
Regulator (maintenance) Pds5 Pds5 Pds5 PDS5A 
PDS5B/AS3/Aprin
PDS5A 
PDS5B/AS3/APRIN
Cohesin acetyltransferase 
(establishment)
Eco1/Ctf7 Eso1 Eco/Deco 
San
Esco1 
Esco2
ESCO1 
ESCO2
Cohesin deacetylase Hos1 ? ? Hdac8 HDAC8
Maintenance
removal
Sororin
ESCO1/2
Establishment
Loading
MAU2/SCC4
SCC2/NIPBL
Ac
Head
Hinge
STAG1/2
RAD21
SMC3 SMC1
WAPL
PDS5
Figure 1 Cohesin complex and cohesin regulators. 
Notes: Ring-embraced model of cohesion. The cohesin complex is formed by four 
proteins, ie, SMC1, SMC3, SCC1/RAD21, and SCC3/STAG. The SMC1, SMC3, and 
RAD21/SCC1 subunits form a ring-like structure. RAD21/SCC1 is the subunit that 
closes the ring formed by SMC (structural maintenance of chromosomes) subunits 
and has been named α-kleisin (closure). The SCC3/STAG protein interacts with 
RAD21/SCC1 to complete the cohesin complex. The adherin loading complex 
consists of two proteins, ie, SCC2/NIPBL and MAU2/SCC4. The acetyltransferases 
(ESCO1/2) acetylate the SMC3 cohesin subunit to establish cohesion of the 
chromatids. The cofactors, PDS5, wAPL, and Sororin, are involved in association 
and/or dissociation with chromatin.
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Gene mutations in the cohesin 
network and human developmental 
disorders
Mutations in the cohesin complex subunits, or cofactors, which 
participate in cohesin ring dynamics, were described some years 
ago as the main genetic factors triggering a variety of rare human 
diseases, known as cohesinopathies. The two best described 
cohesinopathies are Cornelia de Lange syndrome (CdLS, 
OMIM 122470, 300590, 610759, 614701, 300882) and Roberts 
syndrome (and its variant SC phocomelia, OMIM 268300). 
CdLS is an autosomal dominant multiple neurodevelopmental 
disorder, with an estimated occurrence of one in every 10,000. 
It is characterized by mental retardation, facial dysmorphism, 
upper limb abnormalities, and growth delay. Roberts syndrome 
is an autosomal recessive disorder related phenotypically to 
CdLS, with affected patients having craniofacial abnormalities, 
limb reduction, and growth retardation.
Cornelia de Lange syndrome
Patients with CdLS have mutations in the gene encoding 
SCC2/NIPBL, a protein in the adherin complex required for 
loading of the cohesin complex to chromatin (Figure 2).8,9 
In situ analyses of NIPBL expression in mouse embryos 
showed accumulation in the limb buds, branchial arch, and 
craniofacial mesenchyme.8 Similar experiments in human 
embryonic tissue sections revealed NIPBL expression 
in the primordial cartilage of the ulna and various hand 
bones.9 The investigators performing these studies also 
observed expression of this gene in craniofacial tissue, the 
spinal column, and the heart, with defects clearly related 
to the CdLS phenotype. In 2009, Kawauchi et al reported 
generation of mice heterozygous for a gene-trap mutation 
of the first coding exon of the NIPBL gene.14 This mouse 
model showed many features of CdLS, including growth 
retardation, cardiac defects, delayed bone development, and 
hearing deficits, providing the first experimental evidence 
that NIPBL mutations are the cause of CdLS. SCC2/NIPBL/
delangin is a protein with two major isoforms, ie, delangin A 
(long) and delangin B (short). Both have the first 2683 amino 
acid residues in common, but have different carboxy-terminal 
tails containing 121 amino acids (long) and 14 amino acids 
(short).9 NIPBL contains a predicted nuclear localization 
sequence (residues 1108–1124) and five HEAT (protein 
interaction) repeat regions approximately spanning residues 
1750–2350. NIPBL is able to mediate local chromatin 
modifications by recruitment of histone deacetylases and a 
large number of the CdLS mutations found in this protein 
that dramatically affect its function. These results suggest a 
contribution to the syndrome distinct from its canonical role 
in loading cohesin complexes to chromatin.15
After these early f indings, numerous studies have 
been done in patients to identify other mutations in 
proteins related to the dynamics of cohesin. Reports of 
several cases of this syndrome show that mutations in 
the SMC1α and SMC3 cohesin subunits cause a mild 
variant of CdLS.16,17 The disorder triggered by mutations 
in the human gene encoding the SMC1α cohesin subunit 
is frequently denominated as X-linked CdLS because 
the human homolog of yeast Smc1, known as SMC1L1, 
is located in the human X chromosome.16 Later, a single 
mutation was identif ied in human SMC3 in one of 
96 probands tested.17 In CdLS patients with mutated 
SMC1L1 and SMC3, a milder phenotype characterized 
by less significant psychomotor and growth retardation, 
a lower incidence of major malformations, and milder limb 
anomalies has been reported. Because SMC1 and SMC3 
are the cohesin subunits mostly involved in formation 
of the ring-like structure through their hinge and head 
domains (Figure 1), Revenkova et al studied the affinity of 
mutated SMC1α and SMC3 proteins for DNA, focusing 
Maintenance
removal
Sororin
ESCO2
Establishment
Loading
MAU2/SCC4
SCC2/NIPBL
+Ac
-Ac
Head
Hinge
STAG1
RAD21
Cornelia de Lange
Cornelia de Lange
Cornelia de Lange
Cornelia de Lange
Cornelia de Lange
Cornelia de Lange
Roberts syndrome
HDAC8
SMC3 SMC1
WAPL
PDS5B
Figure 2 Cohesin and cohesin regulators in human cohesinopathies.
Notes: Gene mutation occurs in human CdLS and RBS (orange arrows), and results 
in mouse models suggest involvement of cohesin and cohesin regulator genes in 
these human disorders (green arrows). Mutations in the SCC2/NIPBL gene cause the 
most severe phenotype in patients with Cornelia de Lange syndrome. Mutations 
in genes encoding for the cohesin subunits SMC1α, SMC3, and RAD21, and for 
the histone deacetylase, HDAC8, cause a mild variant of this syndrome. Although 
the phenotype of mice lacking PDS5A and/or PDS5B function show developmental 
abnormalities like those in patients with Cornelia de Lange syndrome, currently there 
are no data supporting mutations of these genes as a cause of this cohesinopathy in 
humans. Similarly, to the author’s knowledge, no data have been reported on STAG1 
mutations in patients with Cornelia de Lange syndrome. A human ortholog of yeast 
Eco1 named ESCO2 is mutated in Roberts syndrome, which has a phenotype closely 
related to that seen in Cornelia de Lange syndrome.
Abbreviation: Ac, Acetylation.
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on dimeric hinge domains where several CdLS mutations 
clustered. They found that SMC1α and SMC3 mutations 
mapping to the hinge domains produced higher binding 
affinity between the cohesin complex and DNA than wild-
type proteins in vitro, suggesting modified dynamics of 
chromatin association-dissociation for mutated cohesin 
complexes.18
To identify additional potential causal loci for CdLS, 
Deardorff et al performed a genome-wide array-based copy 
number analysis for 101 individuals with typical CdLS 
and 189 with overlapping features who were negative for 
mutations in previously reported NIPBL, SMC1L1, and 
SMC3 genes associated with CdLS.19 They identified one 
boy with a 8q24.1 interstitial microdeletion that included 
RAD21, which encodes the kleisin subunit that interacts 
with the other three subunits, SMC1α, SMC3, and 
STAG/SCC3, as well as with other regulatory proteins to 
maintain the ring-like structure of the cohesin complex 
(Figures 1 and 2). In addition, these authors identified two 
additional probands with atypical clinical features which 
demonstrated heterozygous de novo RAD21 missense 
mutations (c.1127C . G [p.Pro376 Arg] and c.1753T . C 
[p.Cys585 Arg], respectively).
Therefore, until now, mutations in three cohesin subunits 
(SMC1α, SMC3, RAD21) and in one cohesin-interacting 
protein (NIPBL) have been found in patients with CdLS 
(Figure 2). However, there are results suggesting the 
possibility that mutations in other cohesins and cohesin 
regulators could also contribute to this syndrome in 
humans. In vertebrate somatic cells, there are two cohesin 
complexes that differentiate in the STAG subunit, consisting 
of SMC1α, SMC3, RAD21/SCC1, and either STAG1 or 
STAG2.20–22 Recently, Remeseiro et al studied the phenotypic 
characteristics of mouse embryos lacking STAG1 function.23 
They found that loss of STAG1 function alters transcription 
of genes related to the CdLS phenotype, and hypothesized 
that impaired STAG1 function in gene expression underlies 
the molecular etiology of CdLS.
PDS5 is a regulatory component in the cohesin complex 
that interacts with the cohesin subunits and other cohesin 
cofactors (Figure 1).24 Vertebrates have two homologs of 
PDS5, ie, PDS5A and PDS5B, both of which contribute 
to the dynamics of cohesion. Mice that lack PDS5B have 
multiple developmental anomalies that resemble those 
found in humans with CdLS and die shortly after birth,25 
whereas Pds5B-/- mouse cells show no defects in sister 
chromatid cohesion. In addition, Pds5A deficiency results 
in developmental abnormalities similar to those seen in 
Pds5B knockout mice.26 Although these results, reported 
in both PDS5 knockout models, suggest the involvement 
of these proteins in CdLS, a recent study looking for 
mutations in the PDS5A gene in 137 Italian patients with 
CdLS, who did not have mutations in NIPBL, SMC1L1, 
or SMC3, was negative,27 and mutations in PDS5A and/or 
PDS5B genes have not been reported in human patients 
with CdLS.
Roberts syndrome/SC phocomelia
Mutations in the gene encoding for human ESCO2, 
a homolog to yeast Eco1 acetyltransferase, were found to 
be responsible for the Roberts syndrome and its variant, 
SC phocomelia in humans (Figure 2).10 Cells from patients 
with Roberts syndrome show a lack of cohesion at the 
heterochromatic regions around centromeres and in the 
long arm of the Y chromosome.10 The sequence of human 
ESCO2 contains 601 amino acid residues, including two well 
conserved regions, a Zn finger-like motif and a conserved 
C-terminal acetyltransferase domain. Different mutations in 
the exons and introns of the human Esco2 gene have been 
reported in individuals with Roberts syndrome.28 Most, if 
not all, of these mutations cause loss of acetyltransferase 
activity of ESCO2, providing the first indication that loss of 
acetyltransferase function contributes to the pathogenesis of 
Roberts syndrome.29 Similarly to STAG and PDS5 proteins, 
ESCO acetyltransferases consist of two members, ie, ESCO1 
and ESCO2, in reptiles, birds, fish, and mammals. Although 
ESCO1 mutations have not been reported until now in 
patients with Roberts syndrome, Slavin et al described a 
case with a phenotype of hemivertebral and rib anomalies. 
This individual showed a karyotype of 47 chromosomes 
and genes in the triplicated region, possibly contributing to 
her skeletal phenotype, including GATA6, MC2R, MC5R, 
RBBP8, ESCO1, and ROCK1 among others, and implicating 
the second acetyltransferase member, ESCO1, in her skeletal 
anomalies.30
The function of ESCO acetyltransferases is reversed by 
deacetylases. In humans, this deacetylase has been recently 
identified as HDAC8 (Figure 2), which is responsible for 
deacetylation of the SMC3 cohesin subunit to facilitate 
renewal of the cohesin complex after its dissociation from 
chromatin during prophase or anaphase.31 In this study, the 
authors screened this X-linked gene in 154 individuals with 
CdLS negative for mutations in NIPBL, SMC1a and SMC3, 
RAD21, STAG2, ESCO1, ESCO2, and SCC4. Four missense 
mutations and one nonsense mutation in HDAC8 were 
identified, indicating that loss of HDAC8 activity results in 
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decreased cohesin at specific sites, causing clinical features 
of CdLS.
Link between genotype and 
phenotype in cohesinopathies
Cohesin complex, insulator CTCF 
factor, and transcription regulation
The earliest results connecting the dynamics of the cohesin 
complex with control of gene expression date back to 
1999, when a study by Rollins et al of the Nipped loci from 
Drosophila showed that Nipped-B (the Drosophila homolog 
of human NIPBL) mutations also magnify the effect of a 
gypsy transposable element insertion in the Ultrabithorax 
gene.32 Later, the same researchers found that, in contrast with 
the effect of Nipped-B, the Scc3 component of the cohesin 
complex inhibits long-range activation of the cut gene in 
Drosophila.33 Further, in human cells, STAG2 coactivates a 
multimeric NF-kB reporter construct and enhances activity 
of the p65/RelA transactivation domain.34 Three independent 
research groups have studied the localization of cohesin in 
mammalian chromosomes and found that numerous cohesin 
binding sites overlap with CTCF, an insulator protein that 
participates in blocking enhancer-promoter interactions 
(Figure 3A). Cohesins are also required for the CTCF 
insulation function and for control of H19/IGF2 locus 
imprinting in the G2 and G1 phases in mice. In G1 phase, there 
is no cohesion of sister chromatids, so the role of cohesins in 
the control of H19/IGF2 transcription is independent of their 
function in the cohesion of sister chromatids.11–13 These were 
the initial works suggesting a link between a new cohesin 
function and the molecular causes of cohesinopathies. Since 
then, a large body of research has confirmed this newly 
identified role of cohesin. The insulation-mediated CTCF/
cohesin complex maintains formation of the chromatin loop 
and localization of transcriptional apparatus for promoters 
in the human apolipoprotein gene cluster.35
Chromatin immunoprecipitation (ChIP) experiments 
have been very useful for identification of genes controlled 
by cohesin. The fact that RAD21 is recruited to CTCF sites 
in all Ig loci during development of B lymphocytes suggests 
that the cohesin/CTCF complex may promote formation 
of multiple loops and thus effective recombination of 
V(D)J.36 Liu et al, in a study of 16 mutant cell lines from 
severely affected CdLS probands, identified specific gene 
expression profiles for CdLS.37 The cohesin binding sites 
were significantly reduced in CdLS samples with mutant 
SCC2/NIPBL. However, of the altered control genes in the 
CdLS samples, about 60% were upregulated and 40% were 
downregulated, suggesting that SCC2/NIPBL and cohesin 
have both negative and positive effects on expression. In the 
last two years, a large number of results have been reported 
illustrating the role of the CTCF/cohesin insulation complex 
in the control of expression of distinct differentiation and 
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Figure 3 Models for a chromatin architectural function of cohesin in control of gene expression. (A) Interaction of the cohesin complex with chromatin-bound CTCF 
maintains a chromatin structure in which the enhancer cannot interact with the promoter and behaves as an insulator, repressing gene expression. (B) Loop structure formed 
by the mediator/cohesin complex allows enhancer-promoter interactions promoting gene transcription.
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developmental genes in the immune system, stem cells, 
and germ cells.38,39 Recently, in a transcriptomic analysis of 
marker genes for differences in intellectual disability found 
in patients with Down syndrome, Mégarbané et al showed 
that genes of major histocompatibility complex class II (HLA 
DQA1 and HLA DRB1) were significantly downregulated in 
patients with a low intelligence quotient.40 The intergenic 
region between these genes contains a consensus binding 
sequence for the CTCF/cohesin complex, indicating that 
regulation of gene expression by cohesin would extend 
beyond CdLS and Roberts syndrome.
Cohesin complex and CTCF- 
independent gene regulation
Initial results on this emergent cohesin function suggested 
a requirement for interaction between the cohesin complex 
and the CTCF homodimer (Figure 3A) to form a new 
cohesin/CTCF complex for control of cohesin-mediated 
gene expression, but later studies showed that the cohesin 
complex is also able to regulate the transcription of several 
genes by interacting with a specific transcription factor in a 
manner independent of CTCF.
Two laboratories have shown that the cohesin complex 
is required for morphogenesis of nondividing neurons in 
Drosophila. Using a modified piggyBac vector for insertional 
mutagenesis in a genetic screening41 and by generation of flies 
expressing a modified version of cohesin subunit RAD2142 
(named RAD21TEV), they found that cohesin is essential for 
axon pruning. Looking for genes regulated by cohesin in this 
context, they found that expression of the steroid hormone 
receptor EcR gene, which encodes EcR-B1 protein, an 
essential regulator of axon pruning in the mushroom body, 
is reduced in SMC1α-depleted γ-neurons and that this 
pruning defect is reversed by overexpression of EcR-B1. In 
this case, the results indicated that cohesins facilitated EcR 
transcription. Further, zebrafish embryos lacking cohesin 
subunit RAD21 or SMC3 do not express runx3 and lose 
runx1 expression in early embryonic development.43 This 
positive regulation is the opposite of the effect previously 
described for cohesin function in insulators, but is similar to 
that previously reported for SA2/STAG2.34
Using (ChIP-seq) assays in human breast cancer (MCF-7) 
cells, Schmidt et al identified thousands of genomic sites 
that share cohesin and estrogen receptor-α yet lack CTCF 
binding.44 Further, estrogen-regulated genes are preferentially 
bound by both estrogen receptor-α and cohesin, and the 
silencing of cohesin causes aberrant re-entry of breast cancer 
cells into the cell cycle after hormone treatment. In a human 
hepatocellular carcinoma (HepG2) cell line, liver-specific 
transcription factors colocalized with cohesin independently 
of CTCF at liver-specific targets. These results show for the 
first time that the cohesin complex plays a role in estrogen-
regulated gene expression independently of CTCF by 
interacting with specific transcription factors.45
Gene activation may involve a specific conformation 
of chromatin to facilitate interactions between enhancer-
bound transcription factors/transcriptional coactivators and 
the transcription apparatus at the promoter. A multisubunit 
protein complex known as Mediator interacts with the RNA 
polymerase II enzyme and control of gene expression.45 ChIP-
seq results showed that Mediator, cohesin, and the cohesin 
loading factor, SCC2/NIPBL, co-occupy thousands of sites 
in the embryonic stem cell genome. To confirm interactions 
between Mediator and the cohesin complex, Kagey et al, 
using antibodies against Mediator subunits (Med1, Med12) 
and cohesin (SMC1α, SMC3), coprecipitated both Mediator 
and cohesin subunits. Further, an antibody against NIPBL 
also coprecipitated both cohesin and Mediator subunits.46 
These results confirm that Mediator, cohesin, and NIPBL 
interact, and also suggest that a Mediator/cohesin complex 
would function as a chromatin architect, maintaining the DNA 
loop at specific chromosome sites to activate gene expression 
(Figure 3B). Therefore, involvement of the cohesin complex 
in the regulation of positive and negative transcription points 
to the function of cohesin in gene expression being gene-
dependent.
Fish models of cohesinopathies
Two zebrafish (Danio rerio) models with deficiency in nipbl47 
and esco248 have been generated to explore the molecular 
mechanisms causing the phenotypes observed in CdLS and 
Roberts syndrome. Using morpholino knockdown for the 
two nipbl genes in zebra fish, ie, nipbla and nipblb, it was 
found that a deficiency of these genes produces a spectrum of 
specific heart and gut/visceral organ defects with similarities 
to those found in CdLS. In addition, reduced nipbl function 
has quantitative effects on the expression of multiple genes 
also contributing to the appearance of developmental 
defects.47
Zebrafish embryos deficient for esco2 have phenotypes 
similar to those in humans with Roberts syndrome.48 Esco2-
depleted fish have craniofacial abnormalities characterized 
by missing cartilaginous elements along with truncated 
pectoral fins, much like the phocomelia observed in patients 
with Roberts syndrome. Cells in esco2-mutant fish have 
mitotic defects characterized by disorganized chromosomes 
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spread throughout the cell. This observation is consistent 
with the precocious separation of sister chromatids observed 
in cells of patients with Roberts syndrome.10 However, 
fish mutant for esco2 do not show other anomalies typical 
of Roberts syndrome. Ossification is normal, indicating 
that the developmental pathways for bone are intact in 
these embryos. High levels of cell death contribute to the 
morphology of esco2-depleted embryos without affecting 
specific developmental pathways, and it is suggested that 
cell proliferation defects and apoptosis could be the primary 
cause of the features seen in Roberts syndrome.
On the other hand, similar research in the medaka 
(Oryzias latipes) model of Roberts syndrome shows that 
mutation of esco2 affects expression of several genes.49 
In this study, the investigators demonstrated that an esco2 
mutation (R80S) actually suppresses expression of notch1a 
(a neural development marker) and its downstream genes, as 
well as notch3 (a vascular differentiation marker), suggesting 
an important effect of esco2 mutations on expression of 
developmental genes in Roberts syndrome.
These results show that mutations in different elements 
of the cohesion apparatus have distinct developmental 
outcomes, and suggest that different processes, dysregu-
lation of gene expression, cell proliferation defects, and 
apoptosis could contribute to the anomalies seen in Roberts 
syndrome.
Concluding remarks
The cohesin complex, initially characterized as a ring-
like protein complex that maintains cohesion between 
sister chromatids during segregation of chromosomes, is 
now considered an essential component of the family of 
modulators of chromatin structure during different dynamic 
processes in chromosomes. In many cases, these processes 
aim to safeguard the stability of genetic material and its 
proper distribution to daughter cells, and for those related 
to aneuploidy, genomic instability, and cancer (Figure 4). 
It is known that cohesins are also involved in control of 
gene expression, so it is not surprising that when there are 
errors or problems with the cohesin complex related to its 
role in transcription, one of the likely results is abnormal 
development of the organism.
In recent years, an increasing body of scientific research 
has shown that the functions of cohesin are mediated by the 
actions of other proteins. These molecules, such as SCC2/
SCC4, ESCO, HDAC8, PDS5, WAPL, and Sororin, may be 
necessary for the multiple functions of cohesin, or they may 
contribute to one specific role by spatial-temporal interaction 
with the cohesin complex, eg, CTCF and Mediator, in 
the control of gene expression. Specific post-translational 
modifications of cohesin subunits, such as acetylation, 
phosphorylation, and sumoylation, are also required for 
particular functions of cohesin, suggesting the existence of 
a cohesin code.
These findings point to the denomination of cohesin 
being currently partial and incomplete, and perhaps the 
term “chromosome structure architects” or “architectins” 
would be more appropriate. Therefore, interactions between 
the cohesin complex and specific regulator proteins model 
precise tridimensional structures at local regions of chromatin 
to perform different and specific functions depending on 
spatiotemporal requirements. This architectural function 
of cohesin would modulate the interaction of positive or 
negative regulatory elements in gene transcription during 
development, providing a molecular link between genotype 
and phenotype for the cohesinopathies discussed in this paper. 
Future research on the molecular mechanisms triggering 
alterations in the cohesin network in pathological conditions 
is crucial for determining the genetic and molecular causes 
of these neurodevelopmental disorders in humans, currently 
known as cohesinopathies.
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Notes: Scheme of the main life processes of the cell in which cohesins have been 
functionally characterized and related diseases. The role of cohesin in control of 
gene expression (in red) is the principal focus of this review.
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